Issue brief |

Drug-resistant tuberculosis treatment & access to delamanid in South Africa

Photograph by Sydelle WIllow Smith

South Africa has one of the highest burdens of tuberculosis (TB) and drug-resistant tuberculosis (DR-TB) in the world. In 2015, almost 300,000 people were diagnosed with TB in South Africa, including 20,000 with some form of DR-TB. This briefing document examines the current DR-TB treatment, the role of delamanid in DR-TB treatment, and barriers to accessing delamanid in South Africa.